期刊文献+

瓣膜置换与改良Cox Ⅲ迷宫术同期进行对风湿性心脏瓣膜病伴房颤患者的治疗效果 被引量:2

Valve Replacement and Modified Cox Ⅲ Maze Surgery Over the Same Period of RHD Valve Disease with Atrial Fibrillation Patients
在线阅读 下载PDF
导出
摘要 目的观察瓣膜置换联合改良CoxⅢ迷宫术对风湿性心脏瓣膜病伴房颤患者的治疗效果。方法选取本院收治的风湿性心脏瓣膜病伴房颤患者的临床资料,根据其治疗方式分为对照组和观察组,对照组给予瓣膜置换术,观察组给予瓣膜置换联合改良CoxⅢ迷宫术。比较两组心功能、血压变异性、应激指标和不良反应发生率的差异。结果治疗后,观察组LAD、RAD、LVESD、LVEDD、皮质醇、IL-6和TNF-α水平均显著低于对照组(P<0.05);观察组SDNN、SDANN、RMSSD和PNN50水平均显著高于对照组(P<0.05);两组患者电解质紊乱、低血压和心脏骤停等不良事件发生率比较差异无统计学意义(P>0.05)。结论瓣膜置换联合改良CoxⅢ迷宫术对风心病瓣膜病伴房颤患者有较好的治疗效果,可明显改善患者的心功能,具有良好的应用价值。 Objective To observe the effect of valve replacement combined with modified Cox Ⅲ maze procedure AF patients with RHD of valvular heart disease with atrial therapeutic effect. Methods A retrospective analysis of the clinical data of rheumatic valvular heart disease with atrial fibrillation in our hospital,according to their treatment,divided into control group and observation group,The control group was given valve replacement,and the observation group was given valve replacement combined with improved Cox-Ⅲ maze. The differences of cardiac function,blood pressure variability,stress index and incidence of adverse events were compared between the two groups. Results After treatment,the levels of LAD,RAD,LVESD,LVEDD,cortisol,IL-6 and TNF-alpha in the observation group were lower than those in the control group(P<0.05).The levels of SS,SDANN,RMSSD and PN50 in the observation group were higher than those in the control group(P<0.05).There was no significant difference in the incidence of adverse events such as electrolyte disturbance,hypotension and cardiac arrest between the two groups. Meaning(P>0.05). Conclusion Valve replacement combined with modified Cox Ⅲ maze procedure fibrillation has a good curative effect on rheumatic valvular disease complicated with atrial disease,can improve heart function of patients,has good application value.
作者 陈辛亮 迟立群 梁林 肖巍 CHEN Xinliang;;CHI Liqun;LIANG Lin;XIAO Wei(Beijing Anzhen Hospital,Beijing 100029,China)
出处 《大医生》 2018年第7期17-19,共3页 Doctor
关键词 瓣膜置换 风湿性心脏病 房颤 血压变异性 应激 valve replacement rheumatic heart disease atrial fibrillation blood pressure variability stress
作者简介 陈辛亮,硕士,主治医师,研究方向:心血管疾病。
  • 相关文献

参考文献13

二级参考文献147

  • 1史爱武,陆凤翔,许迪,姚静,王晓伟,盛艳辉,杨荣,李世杰,曹克将,孔祥清.经胸超声心动图评价左心耳封堵术对猪左心房功能及二尖瓣、肺静脉血流动力学的影响[J].中华医学超声杂志(电子版),2007,4(2):67-69. 被引量:3
  • 2侯迈,胡盛寿,宋云虎.心房颤动的外科治疗[J].中国胸心血管外科临床杂志,2005,12(5):346-349. 被引量:7
  • 3王坚刚,孟旭,李晖,崔永强,侯晓彤,高峰,郑斯宏,许春雷.心内膜合并心外膜改良迷宫射频消融治疗心房纤颤[J].中华外科杂志,2007,45(6):415-418. 被引量:13
  • 4马长生,汤日波.心房颤动导管消融进展[J].中国心血管病研究,2007,5(4):241-243. 被引量:6
  • 5武忠,陈保俊,曹彬,李庆国,王东进.心内直视下射频消融改良迷宫术治疗心房颤动[J].中国胸心血管外科临床杂志,2007,14(4):308-309. 被引量:14
  • 6Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [ J ]. Circulation, 2011, 124 (24) :2761-2796.
  • 7Liu X, Ouyang F, Mavrakis H, et al. Complete pulmonary veinisolation guided by three-dimensional electroanatomical mapping for the treatment of paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy [ J ]. Europace, 2005, 7 (5) :421-427.
  • 8Kilicaslan F, Verma A, Saad E, et al. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy [ J ]. Heart Rhythm, 2006, 3 ( 3 ) : 275- 280.
  • 9Callans DJ. Ablation of atrial fibrillation in the setting of hypertrophic cardiomyopathy [ J ]. J Cardiovasc Electrophysiol, 2008, 19 ( 10 ) : 1015-1016.
  • 10Bunch TJ, Munger TM, Friedman PA, et al. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic earcliomyopathy [ J ]. J Cardiovase Eleetrophysiol, 2008, 19 (10) : 1009-1014.

共引文献62

同被引文献25

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部